Table 3.
Univariate Associations of Demographic and Clinical Characteristics with HRQOL. (To identify potential covariates between SBDH and HRQOL).
| Main Dataset (2014 to 2021, Except for 2015), Total Weighted Study N = 229,428, Unweighted n = 3201 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Variables | General HRQoL a | Mental HRQoL a | Physical HRQoL a | |||||||
| Poor | Better | Chi2/p b | Poor | Better | Chi2/p b | Poor | Better | Chi2/p b | ||
| DEMOGRAPHICS (% OTHERWISE SPECIFIED) | ||||||||||
| Age, Median (IQR) | 64 (13) | 65 (14) | 3.41 0.367 c |
57 (15) | 60 (15) | 2.93 0.314 c |
63 (13) | 61 (16) | 3.01 0.840 c |
|
| Age group | 18–64 | 37.5 | 29.0 | 15.42 | 56.5 | 42.6 | 16.51 | 40.5 | 37.3 | 3.62 |
| 65 or older | 61.5 | 70.0 | <0.001 | 42.5 | 57.0 | <0.001 | 58.8 | 61.9 | 440 | |
| Sex | Male | 46.7 | 46.0 | 2.41 | 38.8 | 39.5 | 3.21 | 45.5 | 42.3 | 2.31 |
| Female | 53.3 | 54.0 | 0.674 | 61.2 | 60.5 | 0.822 | 54.5 | 57.7 | 0.237 | |
| CLINICAL CHARACTERISTICS (%) | ||||||||||
| Types of GI cancer | 9.21 <0.001 |
1.21 0.710 |
12.31 <0.001 |
|||||||
| Colorectal | 71.0 | 83.8 | 71.9 | 73.1 | 68.0 | 78.3 | ||||
| Esophageal | 6.0 | 4.2 | 6.5 | 5.5 | 7.3 | 4.4 | ||||
| Liver | 10.2 | 4.5 | 10.0 | 8.4 | 10.6 | 5.8 | ||||
| Pancreatic | 6.3 | 3.9 | 4.5 | 6.6 | 7.3 | 5.3 | ||||
| Stomach | 6.6 | 4.6 | 7.2 | 7.5 | 6.8 | 6.2 | ||||
| Comorbidities | ||||||||||
| Heart Attack | Yes | 18.7 | 7.5 | 13.41 | 16.4 | 10.4 | 15.86 | 18.8 | 12.2 | 2.50 |
| No | 80.2 | 91.9 | <0.001 | 82.3 | 88.2 | 0.023 | 80.4 | 86.7 | 0.003 | |
| Coronary Heart Disease | 15.42 <0.001 |
1.31 0.380 |
16.99 <0.001 |
|||||||
| Yes | 18.8 | 8.0 | 15.7 | 12.2 | 20.3 | 11.5 | ||||
| No | 79.3 | 90.4 | 82.8 | 86.0 | 78.4 | 86.5 | ||||
| Asthma | Yes | 20.2 | 11.3 | 10.51 | 25.6 | 15.5 | 9.48 | 20.5 | 18.8 | 1.21 |
| No | 79.5 | 88.4 | <0.001 | 74.4 | 84.3 | <0.001 | 79.3 | 80.7 | 0.576 | |
| Stroke | Yes | 13.3 | 5.2 | 23.22 | 14.2 | 8.0 | 24.48 | 11.3 | 8.4 | 26.51 |
| No | 85.9 | 94.6 | <0.001 | 84.1 | 91.6 | 0.001 | 87.9 | 91.2 | 0.002 | |
| COPD | Yes | 23.5 | 9.0 | 12.22 | 26.4 | 16.4 | 13.56 | 24.9 | 15.7 | 11.24 |
| No | 75.4 | 90.6 | <0.001 | 71.9 | 61.0 | 0.001 | 74.1 | 83.5 | <0.001 | |
| Diabetes | Yes | 33.3 | 21.4 | 36.21 | 31.3 | 25.2 | 34.59 | 31.6 | 26.9 | 38.83 |
| No | 63.4 | 76.8 | <0.001 | 65.4 | 71.8 | 0.043 | 65.4 | 70.5 | 0.023 | |
| Chronic Arthritis | Yes | 59.2 | 42.9 | 26.08 | 66.4 | 51.4 | 25.57 | 62.2 | 54.3 | 28.21 |
| No | 40.5 | 56.5 | <0.001 | 33.7 | 48.1 | <0.001 | 37.4 | 45.2 | 0.011 | |
| Chronic Kidney Disease | ||||||||||
| Yes | 13.0 | 5.6 | 15.64 | 11.7 | 10.1 | 1.45 | 13.8 | 8.4 | 16.77 | |
| No | 86.0 | 94.0 | <0.001 | 87.1 | 88.9 | 0.556 | 85.2 | 90.9 | 0.012 | |
| Overweight/Obese | 1.22 0.886 |
1.09 0.123 |
1.29 0.323 |
|||||||
| Yes | 31.5 | 31.8 | 30.6 | 36.4 | 31.9 | 32.9 | ||||
| No | 64.3 | 64.3 | 66.4 | 59.9 | 64.5 | 62.1 | ||||
Note. Interquartile range, IQR; Significant findings (p < 0.05) were highlighted in bold. a Levene’s test statistics for the age median variable showed the homogeneity of variance in the ANOVA models: For general HRQoL (0.121, significance = 0.728), for mental HRQoL (0.721, significance = 0.428), and for physical HRQOL (0.851, significance = 0.356). b Chi-square statistics and p values except for the age median variable. c For the age median variable, F/p statistics from ANOVA were used.